We speculate that mutations of MSH2 and AXIN1 may be involved in the PI3K/AKT pathway and play an important role in both EMAST+ and MSI-H tumors originating from gastrointestinal tract cancer. The gene discussed is MSH2; the disease is digestive system cancer.